ACTRN12612000024842已完成未知
Study of the outcome of patients with myeloma nephropathy on treatment with High Cut Off Haemodialysis (HCO-HD) in addition to chemotherapy at the Launceston General Hospital
Clifford Craig Medical Trust Fund0 个研究点目标入组 10 人开始时间: 2012年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with multiple myeloma who have a light chain disease and renal impairment
排除标准
- •patients who have low light chain disease that not cause renal impairment
研究者
相似试验
进行中（未招募）
不适用
Is a PET/MRI scan better than a PET/CT scan at visualising bone lesions and their change with treatment in adults with myeloma?CancerISRCTN15606951King's College London20
进行中（未招募）
不适用
Comparative Trial inMultiple Myeloma Patients of Oral Ibandronic Acid versus Intravenous Zoledronate: a phase III studyMultiple MyelomaEUCTR2005-003770-23-ATF. Hoffmann-La Roche Ltd424
已完成
不适用
The GMMG-HD5 trial: bortezomib-based induction prior to high dose therapy and autologous stem cell transplantation followed by lenalidomide-based consolidation and maintenance therapy in patients with multiple myelomaCancerMultiple myelomaISRCTN05745813Heidelberg University (Germany)504
进行中（未招募）
不适用
Randomised comparisons, in myeloma patients of all ages, of thalidomide, lenalidomide, carfilzomib and bortezomib induction combinations, and of lenalidomide and combination lenalidomide vorinostat as maintenance - Myeloma XIewly diagnosed patients with symptomatic myelomaMedDRA version: 16.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2009-010956-93-GBniversity of Leeds4,000
尚未招募
不适用
Clinical Profile Of Multiple MyelomaCTRI/2021/08/035576Kasturba Medical College